img

Global Gonadotropin-releasing Hormone Antagonists Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gonadotropin-releasing Hormone Antagonists Market Insights, Forecast to 2034

Gonadotropin-releasing hormone antagonists are used to treat advanced prostate cancer. They are also used to treat certain gynecologic conditions and are being studied in the treatment of hormone-sensitive breast cancer. Also called GnRH antagonist, LHRH antagonist, and luteinizing hormone-releasing hormone antagonist.
Global Gonadotropin-releasing Hormone Antagonists market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Gonadotropin-releasing Hormone Antagonists industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Gonadotropin-releasing Hormone Antagonists key manufacturers include AbbVie, Takeda, Astellas, Kissei, Veru Inc, Myovant Sciences, AstraZeneca, Ferring Pharmaceuticals and Jiangsu Hengrui Medicine Co, etc. AbbVie, Takeda, Astellas are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Gonadotropin-releasing Hormone Antagonists were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Gonadotropin-releasing Hormone Antagonists market and estimated to attract more attentions from industry insiders and investors.
Gonadotropin-releasing Hormone Antagonists can be divided into Peptides and Small Molecules, etc. Peptides is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Gonadotropin-releasing Hormone Antagonists is widely used in various fields, such as Prostate Cancer, Endometriosis, Uterine Fibroids and Female Infertility, etc. Prostate Cancer provides greatest supports to the Gonadotropin-releasing Hormone Antagonists industry development. In 2022, global % sales of Gonadotropin-releasing Hormone Antagonists went into Prostate Cancer filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Gonadotropin-releasing Hormone Antagonists market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Gonadotropin-releasing Hormone Antagonists market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie
Takeda
Astellas
Kissei
Veru Inc
Myovant Sciences
AstraZeneca
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co
Segment by Type
Peptides
Small Molecules

Segment by Application


Prostate Cancer
Endometriosis
Uterine Fibroids
Female Infertility
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Gonadotropin-releasing Hormone Antagonists plant distribution, commercial date of Gonadotropin-releasing Hormone Antagonists, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Gonadotropin-releasing Hormone Antagonists introduction, etc. Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Gonadotropin-releasing Hormone Antagonists
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Gonadotropin-releasing Hormone Antagonists Product Introduction
1.2 Market by Type
1.2.1 Global Gonadotropin-releasing Hormone Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Peptides
1.2.3 Small Molecules
1.3 Market by Application
1.3.1 Global Gonadotropin-releasing Hormone Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Prostate Cancer
1.3.3 Endometriosis
1.3.4 Uterine Fibroids
1.3.5 Female Infertility
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gonadotropin-releasing Hormone Antagonists Sales Estimates and Forecasts 2018-2029
2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region
2.2.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2018-2024)
2.2.3 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2024-2029)
2.2.4 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2018-2029)
2.3 Global Gonadotropin-releasing Hormone Antagonists Sales Estimates and Forecasts 2018-2029
2.4 Global Gonadotropin-releasing Hormone Antagonists Sales by Region
2.4.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2018-2024)
2.4.3 Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2024-2029)
2.4.4 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Manufacturers
3.1.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Manufacturers (2018-2024)
3.1.2 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gonadotropin-releasing Hormone Antagonists in 2022
3.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Manufacturers
3.2.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Manufacturers (2018-2024)
3.2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Gonadotropin-releasing Hormone Antagonists Revenue in 2022
3.3 Global Key Players of Gonadotropin-releasing Hormone Antagonists, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Gonadotropin-releasing Hormone Antagonists Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Gonadotropin-releasing Hormone Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Product Offered and Application
3.8 Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Type
4.1.1 Global Gonadotropin-releasing Hormone Antagonists Historical Sales by Type (2018-2024)
4.1.2 Global Gonadotropin-releasing Hormone Antagonists Forecasted Sales by Type (2024-2029)
4.1.3 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2018-2029)
4.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type
4.2.1 Global Gonadotropin-releasing Hormone Antagonists Historical Revenue by Type (2018-2024)
4.2.2 Global Gonadotropin-releasing Hormone Antagonists Forecasted Revenue by Type (2024-2029)
4.2.3 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2018-2029)
4.3 Global Gonadotropin-releasing Hormone Antagonists Price by Type
4.3.1 Global Gonadotropin-releasing Hormone Antagonists Price by Type (2018-2024)
4.3.2 Global Gonadotropin-releasing Hormone Antagonists Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Application
5.1.1 Global Gonadotropin-releasing Hormone Antagonists Historical Sales by Application (2018-2024)
5.1.2 Global Gonadotropin-releasing Hormone Antagonists Forecasted Sales by Application (2024-2029)
5.1.3 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2018-2029)
5.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application
5.2.1 Global Gonadotropin-releasing Hormone Antagonists Historical Revenue by Application (2018-2024)
5.2.2 Global Gonadotropin-releasing Hormone Antagonists Forecasted Revenue by Application (2024-2029)
5.2.3 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2018-2029)
5.3 Global Gonadotropin-releasing Hormone Antagonists Price by Application
5.3.1 Global Gonadotropin-releasing Hormone Antagonists Price by Application (2018-2024)
5.3.2 Global Gonadotropin-releasing Hormone Antagonists Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Gonadotropin-releasing Hormone Antagonists Market Size by Type
6.1.1 US & Canada Gonadotropin-releasing Hormone Antagonists Sales by Type (2018-2029)
6.1.2 US & Canada Gonadotropin-releasing Hormone Antagonists Revenue by Type (2018-2029)
6.2 US & Canada Gonadotropin-releasing Hormone Antagonists Market Size by Application
6.2.1 US & Canada Gonadotropin-releasing Hormone Antagonists Sales by Application (2018-2029)
6.2.2 US & Canada Gonadotropin-releasing Hormone Antagonists Revenue by Application (2018-2029)
6.3 US & Canada Gonadotropin-releasing Hormone Antagonists Market Size by Country
6.3.1 US & Canada Gonadotropin-releasing Hormone Antagonists Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Gonadotropin-releasing Hormone Antagonists Sales by Country (2018-2029)
6.3.3 US & Canada Gonadotropin-releasing Hormone Antagonists Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Gonadotropin-releasing Hormone Antagonists Market Size by Type
7.1.1 Europe Gonadotropin-releasing Hormone Antagonists Sales by Type (2018-2029)
7.1.2 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Type (2018-2029)
7.2 Europe Gonadotropin-releasing Hormone Antagonists Market Size by Application
7.2.1 Europe Gonadotropin-releasing Hormone Antagonists Sales by Application (2018-2029)
7.2.2 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Application (2018-2029)
7.3 Europe Gonadotropin-releasing Hormone Antagonists Market Size by Country
7.3.1 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2018-2029)
7.3.3 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Gonadotropin-releasing Hormone Antagonists Market Size
8.1.1 China Gonadotropin-releasing Hormone Antagonists Sales (2018-2029)
8.1.2 China Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029)
8.2 China Gonadotropin-releasing Hormone Antagonists Market Size by Application
8.2.1 China Gonadotropin-releasing Hormone Antagonists Sales by Application (2018-2029)
8.2.2 China Gonadotropin-releasing Hormone Antagonists Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gonadotropin-releasing Hormone Antagonists Market Size by Type
9.1.1 Asia Gonadotropin-releasing Hormone Antagonists Sales by Type (2018-2029)
9.1.2 Asia Gonadotropin-releasing Hormone Antagonists Revenue by Type (2018-2029)
9.2 Asia Gonadotropin-releasing Hormone Antagonists Market Size by Application
9.2.1 Asia Gonadotropin-releasing Hormone Antagonists Sales by Application (2018-2029)
9.2.2 Asia Gonadotropin-releasing Hormone Antagonists Revenue by Application (2018-2029)
9.3 Asia Gonadotropin-releasing Hormone Antagonists Sales by Region
9.3.1 Asia Gonadotropin-releasing Hormone Antagonists Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Gonadotropin-releasing Hormone Antagonists Revenue by Region (2018-2029)
9.3.3 Asia Gonadotropin-releasing Hormone Antagonists Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Market Size by Type
10.1.1 Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Market Size by Application
10.2.1 Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales by Country
10.3.1 Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 AbbVie Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Recent Developments
11.2 Takeda
11.2.1 Takeda Company Information
11.2.2 Takeda Overview
11.2.3 Takeda Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Takeda Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Takeda Recent Developments
11.3 Astellas
11.3.1 Astellas Company Information
11.3.2 Astellas Overview
11.3.3 Astellas Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Astellas Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Astellas Recent Developments
11.4 Kissei
11.4.1 Kissei Company Information
11.4.2 Kissei Overview
11.4.3 Kissei Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Kissei Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kissei Recent Developments
11.5 Veru Inc
11.5.1 Veru Inc Company Information
11.5.2 Veru Inc Overview
11.5.3 Veru Inc Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Veru Inc Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Veru Inc Recent Developments
11.6 Myovant Sciences
11.6.1 Myovant Sciences Company Information
11.6.2 Myovant Sciences Overview
11.6.3 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Myovant Sciences Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Overview
11.7.3 AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AstraZeneca Recent Developments
11.8 Ferring Pharmaceuticals
11.8.1 Ferring Pharmaceuticals Company Information
11.8.2 Ferring Pharmaceuticals Overview
11.8.3 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ferring Pharmaceuticals Recent Developments
11.9 Jiangsu Hengrui Medicine Co
11.9.1 Jiangsu Hengrui Medicine Co Company Information
11.9.2 Jiangsu Hengrui Medicine Co Overview
11.9.3 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Jiangsu Hengrui Medicine Co Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gonadotropin-releasing Hormone Antagonists Industry Chain Analysis
12.2 Gonadotropin-releasing Hormone Antagonists Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gonadotropin-releasing Hormone Antagonists Production Mode & Process
12.4 Gonadotropin-releasing Hormone Antagonists Sales and Marketing
12.4.1 Gonadotropin-releasing Hormone Antagonists Sales Channels
12.4.2 Gonadotropin-releasing Hormone Antagonists Distributors
12.5 Gonadotropin-releasing Hormone Antagonists Customers
13 Market Dynamics
13.1 Gonadotropin-releasing Hormone Antagonists Industry Trends
13.2 Gonadotropin-releasing Hormone Antagonists Market Drivers
13.3 Gonadotropin-releasing Hormone Antagonists Market Challenges
13.4 Gonadotropin-releasing Hormone Antagonists Market Restraints
14 Key Findings in The Global Gonadotropin-releasing Hormone Antagonists Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Gonadotropin-releasing Hormone Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Peptides
Table 3. Major Manufacturers of Small Molecules
Table 4. Global Gonadotropin-releasing Hormone Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2018-2024)
Table 9. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2024-2029)
Table 10. Global Gonadotropin-releasing Hormone Antagonists Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2018-2024) & (K Units)
Table 12. Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2024-2029) & (K Units)
Table 13. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2018-2024)
Table 14. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2024-2029)
Table 15. Global Gonadotropin-releasing Hormone Antagonists Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Gonadotropin-releasing Hormone Antagonists Sales Share by Manufacturers (2018-2024)
Table 17. Global Gonadotropin-releasing Hormone Antagonists Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Gonadotropin-releasing Hormone Antagonists Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Gonadotropin-releasing Hormone Antagonists, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Gonadotropin-releasing Hormone Antagonists Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Gonadotropin-releasing Hormone Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Gonadotropin-releasing Hormone Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonadotropin-releasing Hormone Antagonists as of 2022)
Table 23. Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Product Offered and Application
Table 25. Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2018-2024) & (K Units)
Table 28. Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2024-2029) & (K Units)
Table 29. Global Gonadotropin-releasing Hormone Antagonists Sales Share by Type (2018-2024)
Table 30. Global Gonadotropin-releasing Hormone Antagonists Sales Share by Type (2024-2029)
Table 31. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Gonadotropin-releasing Hormone Antagonists Revenue Share by Type (2018-2024)
Table 34. Global Gonadotropin-releasing Hormone Antagonists Revenue Share by Type (2024-2029)
Table 35. Gonadotropin-releasing Hormone Antagonists Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Gonadotropin-releasing Hormone Antagonists Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2018-2024) & (K Units)
Table 38. Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2024-2029) & (K Units)
Table 39. Global Gonadotropin-releasing Hormone Antagonists Sales Share by Application (2018-2024)
Table 40. Global Gonadotropin-releasing Hormone Antagonists Sales Share by Application (2024-2029)
Table 41. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Gonadotropin-releasing Hormone Antagonists Revenue Share by Application (2018-2024)
Table 44. Global Gonadotropin-releasing Hormone Antagonists Revenue Share by Application (2024-2029)
Table 45. Gonadotropin-releasing Hormone Antagonists Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Gonadotropin-releasing Hormone Antagonists Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Gonadotropin-releasing Hormone Antagonists Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Gonadotropin-releasing Hormone Antagonists Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Gonadotropin-releasing Hormone Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Gonadotropin-releasing Hormone Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Gonadotropin-releasing Hormone Antagonists Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Gonadotropin-releasing Hormone Antagonists Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Gonadotropin-releasing Hormone Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Gonadotropin-releasing Hormone Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Gonadotropin-releasing Hormone Antagonists Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Gonadotropin-releasing Hormone Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Gonadotropin-releasing Hormone Antagonists Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Gonadotropin-releasing Hormone Antagonists Sales by Country (2024-2029) & (K Units)
Table 60. Europe Gonadotropin-releasing Hormone Antagonists Sales by Type (2018-2024) & (K Units)
Table 61. Europe Gonadotropin-releasing Hormone Antagonists Sales by Type (2024-2029) & (K Units)
Table 62. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Gonadotropin-releasing Hormone Antagonists Sales by Application (2018-2024) & (K Units)
Table 65. Europe Gonadotropin-releasing Hormone Antagonists Sales by Application (2024-2029) & (K Units)
Table 66. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2018-2024) & (K Units)
Table 72. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2024-2029) & (K Units)
Table 73. China Gonadotropin-releasing Hormone Antagonists Sales by Type (2018-2024) & (K Units)
Table 74. China Gonadotropin-releasing Hormone Antagonists Sales by Type (2024-2029) & (K Units)
Table 75. China Gonadotropin-releasing Hormone Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Gonadotropin-releasing Hormone Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Gonadotropin-releasing Hormone Antagonists Sales by Application (2018-2024) & (K Units)
Table 78. China Gonadotropin-releasing Hormone Antagonists Sales by Application (2024-2029) & (K Units)
Table 79. China Gonadotropin-releasing Hormone Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Gonadotropin-releasing Hormone Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Gonadotropin-releasing Hormone Antagonists Sales by Type (2018-2024) & (K Units)
Table 82. Asia Gonadotropin-releasing Hormone Antagonists Sales by Type (2024-2029) & (K Units)
Table 83. Asia Gonadotropin-releasing Hormone Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Gonadotropin-releasing Hormone Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Gonadotropin-releasing Hormone Antagonists Sales by Application (2018-2024) & (K Units)
Table 86. Asia Gonadotropin-releasing Hormone Antagonists Sales by Application (2024-2029) & (K Units)
Table 87. Asia Gonadotropin-releasing Hormone Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Gonadotropin-releasing Hormone Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Gonadotropin-releasing Hormone Antagonists Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Gonadotropin-releasing Hormone Antagonists Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Gonadotropin-releasing Hormone Antagonists Sales by Region (2018-2024) & (K Units)
Table 93. Asia Gonadotropin-releasing Hormone Antagonists Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales by Country (2024-2029) & (K Units)
Table 107. AbbVie Company Information
Table 108. AbbVie Description and Major Businesses
Table 109. AbbVie Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. AbbVie Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. AbbVie Recent Developments
Table 112. Takeda Company Information
Table 113. Takeda Description and Major Businesses
Table 114. Takeda Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Takeda Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Takeda Recent Developments
Table 117. Astellas Company Information
Table 118. Astellas Description and Major Businesses
Table 119. Astellas Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Astellas Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Astellas Recent Developments
Table 122. Kissei Company Information
Table 123. Kissei Description and Major Businesses
Table 124. Kissei Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Kissei Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Kissei Recent Developments
Table 127. Veru Inc Company Information
Table 128. Veru Inc Description and Major Businesses
Table 129. Veru Inc Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Veru Inc Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Veru Inc Recent Developments
Table 132. Myovant Sciences Company Information
Table 133. Myovant Sciences Description and Major Businesses
Table 134. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Myovant Sciences Recent Developments
Table 137. AstraZeneca Company Information
Table 138. AstraZeneca Description and Major Businesses
Table 139. AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. AstraZeneca Recent Developments
Table 142. Ferring Pharmaceuticals Company Information
Table 143. Ferring Pharmaceuticals Description and Major Businesses
Table 144. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Ferring Pharmaceuticals Recent Developments
Table 147. Jiangsu Hengrui Medicine Co Company Information
Table 148. Jiangsu Hengrui Medicine Co Description and Major Businesses
Table 149. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Jiangsu Hengrui Medicine Co Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Gonadotropin-releasing Hormone Antagonists Distributors List
Table 155. Gonadotropin-releasing Hormone Antagonists Customers List
Table 156. Gonadotropin-releasing Hormone Antagonists Market Trends
Table 157. Gonadotropin-releasing Hormone Antagonists Market Drivers
Table 158. Gonadotropin-releasing Hormone Antagonists Market Challenges
Table 159. Gonadotropin-releasing Hormone Antagonists Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Gonadotropin-releasing Hormone Antagonists Product Picture
Figure 2. Global Gonadotropin-releasing Hormone Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Gonadotropin-releasing Hormone Antagonists Market Share by Type in 2022 & 2029
Figure 4. Peptides Product Picture
Figure 5. Small Molecules Product Picture
Figure 6. Global Gonadotropin-releasing Hormone Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Gonadotropin-releasing Hormone Antagonists Market Share by Application in 2022 & 2029
Figure 8. Prostate Cancer
Figure 9. Endometriosis
Figure 10. Uterine Fibroids
Figure 11. Female Infertility
Figure 12. Others
Figure 13. Gonadotropin-releasing Hormone Antagonists Report Years Considered
Figure 14. Global Gonadotropin-releasing Hormone Antagonists Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Gonadotropin-releasing Hormone Antagonists Revenue 2018-2029 (US$ Million)
Figure 16. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2018-2029)
Figure 18. Global Gonadotropin-releasing Hormone Antagonists Sales 2018-2029 ((K Units)
Figure 19. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Gonadotropin-releasing Hormone Antagonists Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Gonadotropin-releasing Hormone Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Gonadotropin-releasing Hormone Antagonists Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Gonadotropin-releasing Hormone Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Gonadotropin-releasing Hormone Antagonists Sales YoY (2018-2029) & (K Units)
Figure 25. China Gonadotropin-releasing Hormone Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Gonadotropin-releasing Hormone Antagonists Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Gonadotropin-releasing Hormone Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Gonadotropin-releasing Hormone Antagonists Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Gonadotropin-releasing Hormone Antagonists in the World: Market Share by Gonadotropin-releasing Hormone Antagonists Revenue in 2022
Figure 32. Global Gonadotropin-releasing Hormone Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2018-2029)
Figure 34. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2018-2029)
Figure 35. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2018-2029)
Figure 36. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Gonadotropin-releasing Hormone Antagonists Revenue Share by Country (2018-2029)
Figure 42. US & Canada Gonadotropin-releasing Hormone Antagonists Sales Share by Country (2018-2029)
Figure 43. U.S. Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2018-2029)
Figure 46. Europe Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2018-2029)
Figure 47. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2018-2029)
Figure 48. Europe Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2018-2029)
Figure 49. Europe Gonadotropin-releasing Hormone Antagonists Revenue Share by Country (2018-2029)
Figure 50. Europe Gonadotropin-releasing Hormone Antagonists Sales Share by Country (2018-2029)
Figure 51. Germany Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 52. France Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 56. China Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2018-2029)
Figure 57. China Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2018-2029)
Figure 58. China Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2018-2029)
Figure 59. China Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2018-2029)
Figure 60. Asia Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2018-2029)
Figure 61. Asia Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2018-2029)
Figure 62. Asia Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2018-2029)
Figure 63. Asia Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2018-2029)
Figure 64. Asia Gonadotropin-releasing Hormone Antagonists Revenue Share by Region (2018-2029)
Figure 65. Asia Gonadotropin-releasing Hormone Antagonists Sales Share by Region (2018-2029)
Figure 66. Japan Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 70. India Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Gonadotropin-releasing Hormone Antagonists Sales Share by Country (2018-2029)
Figure 77. Brazil Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Gonadotropin-releasing Hormone Antagonists Revenue (2018-2029) & (US$ Million)
Figure 82. Gonadotropin-releasing Hormone Antagonists Value Chain
Figure 83. Gonadotropin-releasing Hormone Antagonists Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries